DK536578A - Fremgangsmaade til fremstilling af peptidderivater - Google Patents

Fremgangsmaade til fremstilling af peptidderivater

Info

Publication number
DK536578A
DK536578A DK536578A DK536578A DK536578A DK 536578 A DK536578 A DK 536578A DK 536578 A DK536578 A DK 536578A DK 536578 A DK536578 A DK 536578A DK 536578 A DK536578 A DK 536578A
Authority
DK
Denmark
Prior art keywords
procedure
peptide derivatives
preparing peptide
preparing
derivatives
Prior art date
Application number
DK536578A
Other languages
Danish (da)
English (en)
Inventor
F R Atherton
M J Hall
C H Hassall
R W Lambert
P S Ringrose
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of DK536578A publication Critical patent/DK536578A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36Oxygen or sulfur atoms
    • C07D207/402,5-Pyrrolidine-diones
    • C07D207/4042,5-Pyrrolidine-diones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. succinimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3808Acyclic saturated acids which can have further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006Esters of acyclic acids which can have further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK536578A 1977-12-20 1978-11-29 Fremgangsmaade til fremstilling af peptidderivater DK536578A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB5293877 1977-12-20
GB7842727 1978-11-01

Publications (1)

Publication Number Publication Date
DK536578A true DK536578A (da) 1979-06-21

Family

ID=26267167

Family Applications (1)

Application Number Title Priority Date Filing Date
DK536578A DK536578A (da) 1977-12-20 1978-11-29 Fremgangsmaade til fremstilling af peptidderivater

Country Status (23)

Country Link
EP (1) EP0002534B1 (cs)
JP (1) JPS5492921A (cs)
AT (1) AT366057B (cs)
AU (1) AU4248378A (cs)
BR (1) BR7808342A (cs)
CS (1) CS211394B2 (cs)
CU (1) CU35001A (cs)
DE (2) DE2861537D1 (cs)
DK (1) DK536578A (cs)
ES (1) ES476124A1 (cs)
FI (1) FI783886A7 (cs)
FR (1) FR2450260A1 (cs)
GR (1) GR73085B (cs)
IL (1) IL56208A0 (cs)
IT (1) IT1102401B (cs)
LU (1) LU80671A1 (cs)
MC (1) MC1242A1 (cs)
NL (1) NL7812311A (cs)
NO (1) NO784285L (cs)
NZ (1) NZ189151A (cs)
PT (1) PT68938A (cs)
SE (1) SE7813069L (cs)
ZA (1) ZA786976B (cs)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1307787C (en) * 1986-06-11 1992-09-22 Melanie J. Loots Substituted aminoalkanoylaminoalkyl phosphonate angiotensin converting enzyme inhibitors
CN110156640A (zh) * 2019-06-14 2019-08-23 南京博源医药科技有限公司 一种n-苄氧羰基-氨基酸的制备工艺
CN110143896A (zh) * 2019-06-14 2019-08-20 南京博源医药科技有限公司 一种n-苄氧羰基-l-己氨酸的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1081511B (it) * 1976-07-13 1985-05-21 Hoffmann La Roche Derivati di peptidi e loro preparazione
DE2632188A1 (de) * 1976-07-16 1978-01-26 Hoffmann La Roche Wirkstoffkombinationen
GB1585275A (en) * 1976-07-21 1981-02-25 Roche Products Ltd Peptide derivatives of phosphonic and phosphinic acids

Also Published As

Publication number Publication date
FI783886A7 (fi) 1979-06-21
LU80671A1 (de) 1980-01-22
DE2861537D1 (en) 1982-02-25
AU4248378A (en) 1979-06-28
SE7813069L (sv) 1979-06-21
GR73085B (cs) 1984-01-31
IT7831023A0 (it) 1978-12-19
ZA786976B (en) 1980-07-30
NO784285L (no) 1979-06-21
CU35001A (en) 1981-12-04
AT366057B (de) 1982-03-10
EP0002534B1 (de) 1982-01-13
NZ189151A (en) 1981-05-15
ATA904178A (de) 1981-07-15
CS211394B2 (en) 1982-02-26
NL7812311A (nl) 1979-06-22
BR7808342A (pt) 1979-08-07
MC1242A1 (fr) 1979-10-26
IL56208A0 (en) 1979-03-12
PT68938A (en) 1979-01-01
FR2450260A1 (fr) 1980-09-26
ES476124A1 (es) 1980-07-16
IT1102401B (it) 1985-10-07
JPS5492921A (en) 1979-07-23
DE2854292A1 (de) 1979-07-05
EP0002534A1 (de) 1979-06-27

Similar Documents

Publication Publication Date Title
DK155733C (da) Fremgangsmaade til fremstilling af 4-hydroxy-2-oxo-pyrrolidinderivater
DK349478A (da) Fremgangsmaade til fremstilling af oligoimider
DK539578A (da) Fremgangsmaade til fremstilling af pleuromutilinglycsid-derivater
DK269178A (da) Analogifremgangsmaade til fremstilling af n-alkylpiperidinderivater
DK155279C (da) Fremgangsmaade til fremstilling af 4-hydroxy-2-oxo-pyrrolidinderivater
DK130078A (da) Fremgangsmaade til fremstilling af morfinderivater
DK424577A (da) Fremgangsmaade til fremstilling af analgetisk virksomme pentapeptidderivater
DK531178A (da) Fremgangsmaade til fremstilling af phenylglycinderivater
DK581178A (da) Fremgangsmaade til fremstilling af peptidderivater
DK109478A (da) Fremgangsmaade til fremstilling af polypeptider
DK283177A (da) Fremgangsmade til fremstilling af dipeptidderivater
DK292778A (da) Fremgangsmaade til fremstilling af peptider
DK314177A (da) Fremgangsmade til fremstilling af peptidderivater
DK317277A (da) Fremgangsmade til fremstilling af peptidderivater
DK117677A (da) Fremgangsmade til fremstilling af piperidinderivater
DK470978A (da) R fremgangsmaade til fremstilling af pyrazinobenzoxapinderivate
DK28377A (da) Fremgangsmade til fremstilling af polypeptidderivater
DK497976A (da) Fremgangsmade til fremstilling af alaninderivater
DK494978A (da) Fremgangsmaade til fremstilling af 2-iminoimidazolidinderivater
DK314277A (da) Fremgangsmade til fremstilling af peptidderivater
DK329577A (da) Fremgangsmade til fremstilling af derivater af phenoxyhydroxypropylamin
DK152130C (da) Fremgangsmaade til fremstilling af benzooebaathienopyridinderivater
DK129978A (da) Fremgangsmaade til fremstilling af morfinderivater
DK262678A (da) Fremgangsmaade til fremstilling af quinolinonderivater
DK330077A (da) Fremgangsmade til fremstilling af peptidderivater